50 HatakeyamaH.KatayamaA.KomakiH.NishinoI.GotoY
Actual out-of-pocket cost depends heavily on: Insurance coverage many plans cover these drugs for diabetes more readily than for weight management Indication coverage and pricing differ between the diabetes and obesity brands Manufacturer savings programs and regional pricing Supply both products have experienced periodic shortages driven by surging demand Tirzepatide's commercial success illustrates the scale of this market: its diabetes brand generated roughly $10 billion in a single quarter in 2025
One of the primary ways this medication works is by slowing down gastric emptying
Tingley, D., Yamamoto, T., Hirose, K., Keele, L
So if you have leptin resistance you should evaluate and treat insulin resistance if it is also present
Rios JL, Bomhof MR, Reimer RA, Hart DA, Collins KH, Herzog W